Skip to Content
Merck

P-044

Promethazine hydrochloride

vial of 25 mg, certified reference material, Cerilliant®

Synonym(s):

10-[2-(Dimethylamino)propyl]phenothiazine hydrochloride

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C17H20N2S · HCl
CAS Number:
58-33-3
Molecular Weight:
320.88
EC Number:
200-375-2
UNSPSC Code:
41116107
PubChem Substance ID:
329820037
Beilstein/REAXYS Number:
4166397
MDL number:
MFCD00012652

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Promethazine hydrochloride, vial of 25 mg, certified reference material, Cerilliant®

InChI key

XXPDBLUZJRXNNZ-UHFFFAOYSA-N

InChI

1S/C17H20N2S.ClH/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19;/h4-11,13H,12H2,1-3H3;1H

SMILES string

Cl[H].CC(CN1c2ccccc2Sc3ccccc13)N(C)C

grade

certified reference material

form

solid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

vial of 25 mg

manufacturer/tradename

Cerilliant®

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

forensics and toxicology
pharmaceutical (small molecule)

format

neat

storage temp.

room temp

Quality Level

300

Gene Information

human ... HRH1(3269)

Looking for similar products? Visit Product Comparison Guide

General description

Promethazine is a phenothiazine analog prescribed for treatment of motion sickness, nausea, vomiting and allergies. This Certified Reference Material is suitable for GC/MS or LC/MS methods in promethazine testing for forensic analysis, urine drug testing, or clinical toxicology. Sold under the trade names Phenergan® and Phenadoz®, promethazine has antihistamine, sedative, and mild antipsychotic effects. The compound has also been been found in the recreational drug "Purple Drank."

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Phenadoz is a registered trademark of Watson Laboratories, Inc.
Phenergan is a registered trademark of Delcor Asset Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gaeul Han et al.
Current issues in molecular biology, 43(3), 1669-1684 (2021-10-27)
Postmenopausal syndrome refers to symptoms caused by the gradual decrease in female hormones after mid-40 years. As a target organ of estrogen, decrease in estrogen causes various changes in brain function such as a decrease in choline acetyltransferase and brain-derived
Elisa Izquierdo et al.
Cancer discovery (2021-11-06)
The survival of children with DIPG remains dismal, with new treatments desperately needed. In a prospective biopsy-stratified clinical trial, we combined detailed molecular profiling and drug screening in newly-established patient-derived models in vitro and in vivo. We identified in vitro
Cheryl C Y Loh et al.
PloS one, 9(10), e110800-e110800 (2014-10-25)
Chloroquine was a cheap, extremely effective drug against Plasmodium falciparum until resistance arose. One approach to reversing resistance is the inhibition of chloroquine efflux from its site of action, the parasite digestive vacuole. Chloroquine accumulation studies have traditionally relied on
Mario Schietroma et al.
Journal of the American College of Surgeons, 220(5), 921-933 (2015-04-05)
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. An independent statistical analysis based on the summary data tables and statistical results reported in the
Shigeru Hishinuma et al.
Biochemical pharmacology, 91(2), 231-241 (2014-07-30)
Differential binding sites for first- and second-generation antihistamines were indicated on the basis of the crystal structure of human histamine H1 receptors. In this study, we evaluated differences between the thermodynamic driving forces of first- and second-generation antihistamines for human
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service